LifeStance Health Group, Inc. 8-K

What Happened
On May 7, 2026, LifeStance Health Group, Inc. announced its results of operations for the quarter ended March 31, 2026. The company issued a press release reporting the Q1 2026 quarterly results and furnished a supplemental slide presentation under Regulation FD. The Form 8-K was signed by Ryan McGroarty, Chief Financial Officer, on May 7, 2026.

Key Details

• Filing date: May 7, 2026 (Form 8-K).
• Reporting period: Quarter ended March 31, 2026 (Q1 2026).
• Press release announcing results furnished as Exhibit 99.1.
• Supplemental slide presentation (Regulation FD disclosure) furnished as Exhibit 99.2.

Why It Matters
This 8-K signals that LifeStance has publicly released its Q1 2026 earnings and related presentation materials. Retail investors should read the press release and slides for the specific earnings and revenue figures, trends in patient/visit metrics, operating performance, cash flow, and any management commentary or guidance that could affect the stock. The Regulation FD slide presentation means the company provided the same information broadly to the market.